Beijing Printed Electronics Engineering Technology Research Center, Beijing Institute of Graphic Communication, Beijing 102600, PR China.
Department of Chemistry and Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, PR China.
J Control Release. 2017 Aug 10;259:40-52. doi: 10.1016/j.jconrel.2017.03.018. Epub 2017 Mar 10.
Spurred on by advances in materials chemistry and nanotechnology, scientists have developed many novel nanopreparations for cancer diagnosis and therapy. To treat complex malignant tumors effectively, multifunctional nanomedicines with targeting ability, imaging properties and controlled drug release behavior should be designed and exploited. The therapeutic efficiency of loaded drugs can be dramatically improved using redox-responsive nanoplatforms which can sense the differences in the redox status of tumor tissues and healthy ones. Redox-sensitive nanocarriers can be constructed from both organic and inorganic nanomaterials; however, at present, drug delivery nanovectors progressively lean towards inorganic nanomaterials because of their facile synthesis/modification and their unique physicochemical properties. In this review, we focus specifically on the preparation and application of redox-sensitive nanosystems based on mesoporous silica nanoparticles (MSNs), carbon nanomaterials, magnetic nanoparticles, gold nanomaterials and other inorganic nanomaterials. We discuss relevant examples of redox-sensitive nanosystems in each category. Finally, we discuss current challenges and future strategies from the aspect of material design and practical application.
受到材料化学和纳米技术进步的推动,科学家们已经开发出许多用于癌症诊断和治疗的新型纳米制剂。为了有效治疗复杂的恶性肿瘤,需要设计和开发具有靶向能力、成像特性和控制药物释放行为的多功能纳米药物。使用氧化还原响应纳米平台可以显著提高负载药物的治疗效率,这些纳米平台可以感知肿瘤组织和健康组织之间氧化还原状态的差异。氧化还原敏感的纳米载体可以由有机和无机纳米材料构建;然而,目前,由于其易于合成/修饰和独特的物理化学性质,药物输送纳米载体逐渐倾向于无机纳米材料。在本文中,我们专门关注基于介孔硅纳米粒子(MSNs)、碳纳米材料、磁性纳米粒子、金纳米材料和其他无机纳米材料的氧化还原敏感纳米系统的制备和应用。我们讨论了每个类别中氧化还原敏感纳米系统的相关实例。最后,我们从材料设计和实际应用的角度讨论了当前的挑战和未来的策略。
J Control Release. 2017-3-10
J Control Release. 2015-4-21
Adv Mater. 2019-7-28
J Colloid Interface Sci. 2016-12-1
Cancer Treat Rev. 2012-10
J Nanobiotechnology. 2024-9-28
MedComm (2020). 2024-7-20
Nanoscale Adv. 2022-7-28
RSC Adv. 2020-6-25